Positive predictive value (PPV) of mammography and breast ultrasound in BI-RADS categories 4 and 5 and relationship to pathological results
Main Article Content
Abstract
Background: Mammography and breast ultrasound are screening methods for diagnosing breast lesions. Reports of BI-RADS 4 and 5 should be verified with pathology because there is a high chance of cancer.
Objectives: This research aims to predict the positive predictive value (PPV) of mammography and breast ultrasound in BI-RADS categories 4 and 5 and to study the relationships with pathological results.
Methods: This retrospective descriptive study was conducted with 442 cases included. Descriptive statistics analyzed general data, clinical data records, and PPV—the relationship between pathological results using the Chi-Square.
Results: 53.1% of the samples who were found with a lump in the breast were diagnosed with breast cancer. 22.4 % of the samples were found with a lump in the breast, a fibroadenoma. 19.7% of the samples had the PPVs of mammography and breast ultrasound in BI-RADS categories 4A, 4B, 4C, and 5. A lump size of 2 cm. or more had a higher risk of developing breast cancer than those with a lump size less than 2 cm at 2.68 times. The BI-RADS 5 group had a higher risk of developing breast cancer than BI-RADS 4 at 16.95 times.
Conclusions: The size of the lumps found and the PPVs of the BI-RADS 4 and 5 can effectively predict the likelihood of developing breast cancer.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวิทยาลัยพยาบาลบรมราชชนนี จังหวัดนนทบุรี
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับวิทยาลัยพยาบาลบรมราชชนนี จังหวัดนนทบุรี และคณาจารย์ท่านอื่น ในวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
References
Urairerkkul C. Overview of the situation and strategies for breast cancer control. Department of Health [Internet]. 2022 [cited 2022 May 28]; Available from: URL:http://doh.hpc.go.th/bse/issueDisplay.php?id=631&category=C10&issue=Breast%20Cancer. (in Thai).
National Cancer Institute, Department of Medical Services, Ministry of Public Health. Guidelines for diagnostic screening and treatment of breast cancer. Bangkok: Kosit Printing Company Limited; 2017. (in Thai).
American College of Radiology. Breast imaging reporting and data system, breast imaging atlas. fifth edition. Reston, Virginia: American College of Radiology; 2013.
Suttawas A. Positive predictive value and biopsy rate of breast cancer in BI-RADS category 4 and 5 breast lesions. Region 4-5 Medical Journal. 2018;37(2):174-82. (in Thai).
Suvendu KM, Abhisek M, Tapan KS, Rashmita BN, Prafulla KD, Bhagyalaxmi N. The positive predictive values of the breast imaging reporting and data system (BI-RADS) 4 lesions and its mammographic morphological features. Indian J Surg Oncol. 2021;12(1):182-9. doi:10.1007/s13193-02 0-01274-5.
Kanchanasuttirak W. Positive predictive value of breast imaging reporting and data systems category 5 in breast cancer diagnosis. Vajira Medical Journal: Journal of Urban Medicine. 2022;66(1): 69-76. (in Thai).
Singhakarn C. Effectiveness of report mammogram BIRADS 4 and 5 in Phang-nga Hospital. Region 11 Medical Journal. 2021;35(1):113-23. (in Thai).
Cancer Registry Unit, National Cancer Institute Thailand. Cancer in Thailand. Bangkok: New Thammada Press; 2015. (in Thai).
National Cancer Institute, Department of Medical Services, Ministry of Public Health. Recommendations for appropriate breast cancer screening for Thailand. [Internet]. 2020 [cited 2022 December 20]; Available from: https://www.nci.go.th/th/cpg (in Thai).
He P, Cui LG, Chen W, Yang RL. Subcategorization of ultrasonographic BI-RADS category 4: Assessment of diagnostic accuracy in diagnosing breast lesions and influence of clinical factors on positive predictive value. Ultrasound Med Biol. 2019;(45)5: 1253-8. doi: 10.10 16/j.ultrasmedbio.2018.12.008.
Elverici E, Barca AN, Aktas H, Ozsoy A, Zengin B, Cavusoglu M, et al. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation. Diagn Interv Radiol. 2015; 21:(3)189-94.
Sirikunakorn P, Marukatat N, Tangjitgamol S, Loharamtaweethong K. Positive predictive value of malignancy in BI-RADS 4 and 5 breast lesions. Vajira Medical Journal: Journal of Urban Medicine. 2014;58(2): 1–11. (in Thai).